The year 2025 marked a major leap for AI in health care, with breakthroughs in drug discovery, diagnostics, genomics and ...

US firm, backed by Fosun and Tencent, expands research base in China as it develops an AI-powered drug-discovery tool Biotech ...

Seattle biotech startup Rhizome Research has emerged from stealth with technology for creating small-molecule drug candidates ...

AI therapeutics company built on causal biology, today announced the publication of research in Nature Communications validating its POSH (Pooled Optical Screening in Human cells) platform. The study ...

After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma ...

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...

Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. In the preclinical stages, for example, companies are using advanced AI ...

The research, published in Nature Communications, aims to improve drug safety and effectiveness by accounting for genetic ...

Regina Barzilay is a School of Engineering Distinguished Professor of AI & Health in the department of computer science and the AI faculty lead at MIT Jameel Clinic. She develops machine learning ...

Transforming drug discovery with generative AI Variational AI is using its Enki platform to explore uncharted regions of the chemical space, accelerating the discovery and development of ...